UnitedHealth (NYSE:UNH) and Dexcom (NSDQ:DXCM) are joining forces to launch an individualized glucose management pilot program to help people with Type II diabetes manage their condition in real-time using wearable tech.
People using UnitedHealth’s Medicare Advantage plan are eligible to use Dexcom’s mobile continuous glucose monitoring system to track their blood sugar levels. Participating in the program also gives people access to personalized diabetes coaching and an activity tracker, the companies reported this week.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.